Ipamorelin
Compoundable (Rx)Growth Hormone Secretagogues · GH Release
Ipamorelin is a selective growth hormone secretagogue that stimulates the pituitary gland to produce growth hormone without significantly affecting cortisol or prolactin levels.
What is Ipamorelin?
Ipamorelin is a selective growth hormone secretagogue that stimulates the pituitary gland to produce growth hormone without significantly affecting cortisol or prolactin levels. It is considered one of the safest and most selective GH-releasing peptides available.
Also known as: NNC 26-0161
How Does Ipamorelin Work?
Selectively binds to ghrelin/GHS receptors in the pituitary gland, stimulating the release of growth hormone in a pulsatile, physiological manner. Unlike other GHRPs, it does not significantly increase ACTH, cortisol, prolactin, or aldosterone, making it highly selective.
What is Ipamorelin Used For?
- Growth hormone optimization
- Anti-aging
- Fat loss
- Muscle recovery
- Sleep improvement
Potential Side Effects
- Headache
- Flushing
- Dizziness
- Injection site irritation
- Water retention (mild)
Contraindications
- Active cancer
- Pregnancy
- Pituitary disorders
FDA Legal Status
United States — FDA
Compoundable (Rx)Related Peptides
CJC-1295
Compoundable (Rx)Growth Hormone Secretagogues
CJC-1295 is a synthetic analog of growth hormone-releasing hormone (GHRH) that stimulates sustained growth hormone relea...
Sermorelin
Compoundable (Rx)Growth Hormone Secretagogues
Sermorelin is a synthetic analog of the first 29 amino acids of natural growth hormone-releasing hormone (GHRH). It was ...
GHRP-2
Research OnlyGrowth Hormone Secretagogues
GHRP-2 is one of the most potent growth hormone releasing peptides, stimulating GH release through the ghrelin receptor....
Head-to-head comparisons:
Frequently Asked Questions
What does ipamorelin do?
Is ipamorelin better than HGH?
How long does ipamorelin take to work?
Quick Facts
- Legal Status (USA)
- Compoundable (Rx)
- Evidence Rating
- BModerate Evidence (Some Human Data)
- Class / Subclass
- Growth Hormone Secretagogues / GH Release
- Administration
- subcutaneous
- Typical Dosage
- 200-300mcg 2-3x daily
- Half-Life
- ~2 hours
- Year Discovered
- 1998
Sources
Last updated: 2026-04-01
Sources & references
Primary sources used for the dosing, mechanism, side-effect, and regulatory claims on this page. Verify time-sensitive information (regulatory status, prescribing details) on the source before relying on it for medical decisions. See our disclaimer.
- PubMed PMID 9849822 — peer-reviewed primary literature on Ipamorelin.
- FDA Federal Register — official notice record for FDA regulatory actions and Category 1 / 503A bulk-substance updates.